
Sindhu Bhaskaran Pillai
About Sindhu Bhaskaran Pillai
Data last updated:
Sindhu Bhaskaran Pillai is a Director at Flex And Oncology Clinical Research Private Limited (since 2019), Director at Genpro Life Sciences India Private Limited (since 2019) and Director at Wynaut Labs Private Limited (since 2026), and holds 2 more current directorships. The companies operate in Business Outsourcing, Service and Professional Services. The 2 current companies with reported revenue have a combined latest revenue of ₹33.38 Cr; the largest is Flex And Oncology Clinical Research Private Limited at ₹33.24 Cr (FY 2025). Earlier, Sindhu Bhaskaran Pillai was a Director at Clap Research Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Jul 2019 | 2019 | ₹33.24 Cr (FY 2025) | Active | |
| Director | 10 Jan 2019 | 2016 | ₹13.6 Lakh (FY 2017) | Active | |
| Director | 28 Jan 2026 | 2026 | Active | ||
| Designated Partner | 25 Jun 2025 | 2025 | Active | ||
| Director | 19 Jun 2019 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Sep 2016 | 2016 | ₹1.37 Cr (FY 2021) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sindhu Bhaskaran Pillai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Patricia Bronke Mcnamara | 10450467 | Flex And Oncology Clinical Research Private Limited | Director |
| Anoop Parameswarakurup Ambika | 00425436 | Genpro Life Sciences India Private Limited , Katalyst Business Accelerator Services Foundation | Director |
| Dev Nandan Anoop | 11508757 | Wynaut Labs Private Limited | Director |
| Shreyas Sanjay | 11169261 | Ananthamaya Foods Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sindhu Bhaskaran Pillai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sindhu Bhaskaran Pillai
Sindhu Bhaskaran Pillai currently holds 5 directorships: Flex And Oncology Clinical Research Private Limited (Director, since 04 Jul 2019, revenue ₹33.24 Cr (FY 2025)); Genpro Life Sciences India Private Limited (Director, since 10 Jan 2019, revenue ₹13.6 Lakh (FY 2017)); Wynaut Labs Private Limited (Director, since 28 Jan 2026); Ananthamaya Foods Llp (Designated Partner, since 25 Jun 2025); Katalyst Business Accelerator Services Foundation (Director, since 19 Jun 2019).
Sindhu Bhaskaran Pillai was first appointed on 22 Sep 2016 as Director at Clap Research Private Limited. The most recent appointment on record is 28 Jan 2026 at Wynaut Labs Private Limited.
The 2 current companies of Sindhu Bhaskaran Pillai that report revenue have a combined latest revenue of ₹33.38 Cr: Flex And Oncology Clinical Research Private Limited ₹33.24 Cr (FY 2025); Genpro Life Sciences India Private Limited ₹13.6 Lakh (FY 2017).
Sindhu Bhaskaran Pillai held 1 earlier board appointment: Clap Research Private Limited (Director, from 22 Sep 2016).
The current boards of Sindhu Bhaskaran Pillai's companies include Patricia Bronke Mcnamara (Flex And Oncology Clinical Research Private Limited), Anoop Parameswarakurup Ambika (Genpro Life Sciences India Private Limited), Dev Nandan Anoop (Wynaut Labs Private Limited), Shreyas Sanjay (Ananthamaya Foods Llp).